Table 1 Correlation of FSTL1 mRNA expression and clinical prognosis in GC with different clinicopathological factors by Kaplan-Meier plotter

 Female

236

1.89 (1.33-2.7)

0.00035

201

1.97 (1.35-2.87)

0.00036

 Male

545

1.62 (1.31-2.01)

7.90E-06

438

1.6 (1.26-2.03)

9.20E-05

 I

67

1.87 (0.69-5.07)

0.21

60

0.47 (0.14-1.57)

0.21

 II

140

1.71 (0.94-3.12)

0.075

131

1.6 (0.82-3.12)

0.17

 III

305

1.75 (1.31-2.34)

0.00012

186

1.94 (1.34-2.81)

0.00036

 IV

148

1.89 (1.28-2.81)

0.0013

141

1.58 (1.05-2.37)

0.026

 2

241

2.14 (1.4-3.27)

3.00E-04

239

1.85 (1.23-2.8)

0.0029

 3

204

1.72 (1.21-2.45)

0.0022

204

1.6 (1.14-2.26)

0.0063

 4

38

3.17 (1.3-7.71)

0.0074

39

4.67 (1.87-11.66)

0.00035

 0

74

1.75 (0.76-4.06)

0.19

72

1.78 (0.78-4.08)

0.17

 1

225

2.34 (1.55-3.53)

3.10E-05

222

2.35 (1.59-3.48)

9.10E-06

 2

121

1.91 (1.22-2.99)

0.0043

125

2.06 (1.33-3.18)

0.00088

 3

76

2.4 (1.4-4.12)

0.0011

76

1.96 (1.15-3.34)

0.012

 1+2+3

422

2.15 (1.66-2.8)

5.00E-09

423

2.19 (1.7-2.82)

5.40E-10

 0

344

2.04 (1.55-2.7)

2.90E-07

443

2.08 (1.59-2.71)

3.30E-08

 1

56

2.05 (1.12-3.75)

0.018

56

1.57 (0.85-2.88)

0.14

 Intestinal

320

2.32 (1.69-3.19)

1.00E-07

263

2.01 (1.39-2.89)

0.00014

 Diffuse

241

2.05 (1.45-2.89)

3.50E-05

231

2.07 (1.46-2.93)

2.60E-05

 Mix

32

2.29 (0.82-6.35)

0.1

28

2.71 (0.76-9.64)

0.11

 Poor

165

1.37 (0.92-2.05)

0.12

121

1.42 (0.9-2.25)

0.13

 Moderate

67

1.95 (0.99-3.86)

0.051

67

2.32 (1.19-4.52)

0.011

 Well

32

13.34 (3.03-58.81)

1.80E-05

*

*

*

 Negative

532

1.63 (1.3-2.04)

1.70E-05

408

1.75 (1.35-2.27)

1.50E-05

 Positive

344

1.67 (1.27-2.19)

0.00019

233

1.75 (1.2-2.55)

0.0034